Results 51 to 60 of about 6,623 (181)
This single‐center retrospective study of pediatric solid organ transplant recipients found that vaccine‐specific serologies were rarely utilized to guide post‐transplant vaccination practices. Additionally, older age at the time of transplant, private insurance, and heart transplantation were identified as risk factors for delayed and incomplete non ...
Adam Z. Blatt +3 more
wiley +1 more source
Past and Present Vaccinations in Sweden
Acta Paediatrica, EarlyView.
Sven Arne Silfverdal
wiley +1 more source
Aim. Study cytokine status in mice immunized with vaccines containing acellular pertussis component. Materials and methods. Vaccines developed in Mechnikov RIVS - acellular pertussis vaccine (aPV) and adsorbed pertussis-diphtheria-tetanus vaccine (aDTaP),
E. M. Zaitsev +5 more
doaj +1 more source
Background In 2024 England, in common with many other countries, experienced a pertussis resurgence the cause of which is unclear. We used a pertussis transmission model, previously developed to investigate the cause of the pertussis resurgence in ...
Yoon Hong Choi +2 more
doaj +1 more source
Less reactogenic whole-cell pertussis vaccine confers protection from Bordetella pertussis infection
Pertussis resurged over the last decade in most countries that replaced the traditional whole-cell pertussis vaccines (wP) by the less reactogenic acellular pertussis vaccines (aP).
Karolína Škopová +6 more
doaj +1 more source
Experience and challenges on influenza and pertussis vaccination in pregnant women
Young infants contribute to relatively high burden of vaccine-preventable diseases, including infections by influenza virus and Bordetella pertussis. Vaccination of pregnant women can enhance transplacental transfer of protective antibody to the fetus ...
Shabir A. Madhi, Marta C. Nunes
doaj +1 more source
Pertussis and the acellular vaccines
Morbidity and mortality from pertussis continue to be a problem worldwide, both because the organism is difficult to eradicate and because there is non-compliance with vaccination, often owing to concerns about side effects of the whole-cell vaccine. The new acellular vaccines have fewer side effects and appear to be efficacious, although costly.
Margaret Burgess, Jill Forrest
openaire +1 more source
Development of High-Throughput Serum Bactericidal Assays for Bordetella pertussis to Evaluate BPZE1
Background/Objectives: Pertussis, caused by Bordetella pertussis, remains a global health problem, despite high vaccine coverage. In countries with high acellular pertussis vaccine (aPV) coverage, pertactin-negative B.
Peter Goldstein +9 more
doaj +1 more source
IntroductionThe diphtheria, tetanus, and acellular pertussis combined vaccine (DTaP) is a trivalent formulation containing acellular pertussis antigens, diphtheria toxoid, and tetanus toxoid, and provides simultaneous protection against pertussis ...
Han Chu +62 more
doaj +1 more source

